Document is current
Any future updates will be listed below
-
Authors
Cui, Mengtian
Su, Qin
Yip, Mitchell
McGowan, Jackson
Punzo, Claudio
Gao, Guangping https://orcid.org/0000-0003-0097-9012
Tai, Phillip W. L. https://orcid.org/0000-0001-7409-8344
-
Funding
Funding for this research was provided by:
The Bassick Family Foundation Award, BRIDGE Fund Award
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (R01NS076991, P01HL131471)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (R01AI121135, U19AI149646)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (UG3HL147367, R01HL097088, R01HL152723, UH3HL147367)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
- License Information
-
More Information
Article History
Received: 4 April 2024
Revised: 3 August 2024
Accepted: 6 August 2024
First Online: 12 August 2024
Competing interests
: GG is a scientific co-founder of Voyager Therapeutics and Aspa Therapeutics and holds equity in these companies. GG and PWLT are inventors on patents with royalties licensed to biopharmaceutical companies. GG, CP, and PWLT also received sponsored research support from Kanghong Pharmaceuticals for unrelated research. The remaining authors declare no competing interests.
: All mouse experiments were conducted at UMass Chan Medical School following protocols and procedures and were approved by the UMass Chan Medical School Institutional Animal Care and Use Committee.
